Written question asked by Lord Alton of Liverpool (Crossbench), in the House of Lords. It was answered by Earl Howe (Conservative) on Thursday, 9 December 2010.

Embryology

Question: To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 30 June (WA 282) and 23 November (WA 297), how the Human Fertilisation and Embryology Authority (HFEA) scrutinised the cloning of embryos using nuclei from a patient with type 1 diabetes and concluded that this could ““be applied in developing treatments for serious disease””, if the steps to be taken to counteract the autoimmune response have never been detailed in any relevant research application submitted to the HFEA.

Answer: The Human Fertilisation and Embryology Authority has advised its licence committees consider all applications for licences for human embryo research in accordance with the criteria set out in the Human Fertilisation and Embryology Act 1990, as amended. The grounds for a committee’s decision are recorded in the relevant minutes, which are published on its website at: www.hfea.gov.uk.

Secondary information

Type: Written question
Reference: 4680; 723 c76WA
Session: 2010-12
Related items: Embryology
Wednesday, 30 June 2010
Written questions
House of Lords; Embryology
Tuesday, 23 November 2010
Written questions
House of Lords; Embryology
Monday, 20 December 2010
Written questions
House of Lords
Subjects: Clones Diabetes Licensing Human embryo experiments Human Fertilisation and Embryology Authority Medical treatments Stem cells
Link: View this Written question on www.publications.parliament.uk